AFT Pharmaceuticals Ltd (OTCPK:AFTPF)
$ 0 0 (0%) Market Cap: 205.17 Mil Enterprise Value: - PE Ratio: 25.89 PB Ratio: 3.63 GF Score: 90/100

Half Year 2023 AFT Pharmaceuticals Ltd Earnings Call Transcript

Nov 23, 2022 / 09:00PM GMT
Operator

Thank you for standing by, and welcome to the AFT Pharmaceuticals FY 2023 Half Year Results Analyst Briefing. (Operator Instructions)

I would now like to hand the conference over to Dr. Hartley Atkinson, Managing Director. Please go ahead.

Hartley Atkinson
AFT Pharmaceuticals Limited - Co-Founder, CEO, MD & Executive Director

Good. Thank you very much, and thank you, everyone, for attending. So look, perhaps just to work for initially the investor presentation, to flip through that, I'll just talk to the pages. So there's Page #1 is the cover page. Page #2 is just a disclaimer. So please be aware of the details of that.

Now moving on to Page 3. What this is looking at is basically our growth from -- and we have had strong growth across our local Australasian business. Just a background, we have 150-plus products across 7 key therapeutic areas and they're distributed across 6,800 pharmacies. So there's about 5,800 in Australia and about 1,000 in New Zealand. Asia, we -- another region, we have a broad range of products sold in the Asia

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot